Mizuho Downgrades ZoomInfo GTM to Underperform Amid Revenue Concerns Anthropic Tops 2026 CNBC Disruptor 50 List as Enterprise AI Adoption Surges Supernus Pharmaceuticals SUPN Reports Strong Q1 2026 Revenue NA EPS Beats Musk and Altman Shift Legal Battle to Wall Street as SpaceX and OpenAI Near Landmark IPOs